Global Cytokines Market by Type (Chemokines, Colony-Stimulating Factors, Interferons), Source (Natural Cytokines, Recombinant Cytokines), Route of Administration, Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Cytokines Market by Type (Chemokines, Colony-Stimulating Factors, Interferons), Source (Natural Cytokines, Recombinant Cytokines), Route of Administration, Application, End-User - Forecast 2024-2030

Report
185 Pages
March 2024
Region: Global
360iResearch™
ID: 5887598

UP TO €843EUR$875USD£721GBP OFF until Dec 31^st 2024

The Cytokines Market size was estimated at USD 81.76 billion in 2023, USD 86.98 billion in 2024, and is expected to grow at a CAGR of 8.97% to reach USD 149.25 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cytokines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cytokines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cytokines Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alkem Laboratories Ltd., Amgen Inc., AstraZeneca PLC, Bio-Techne Corporation, Bristol-Myers Squibb Company, Cipla Ltd., Emcure Pharmaceuticals Ltd., Enzo Life Sciences, Inc., GlaxoSmithkline PLC, Glenmark Pharmaceuticals Ltd., Global Calcium Private Limited, Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Ipca Laboratories Ltd., Johnson & Johnson Services, Inc., Manus Aktteva Biopharma LLP, Merck KGaA, Novartis AG, Pfizer Inc., Reliance Life Sciences, Sanofi SA, Sartorius AG, Taj Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB S.A.

Market Segmentation & Coverage

This research report categorizes the Cytokines Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Chemokines
- Colony-Stimulating Factors
- Interferons
- Interleukins
- Tumor Necrosis Factors
Source
- Natural Cytokines
- Recombinant Cytokines
Route of Administration
- Injectable
- Oral
Application
- Autoimmune Diseases
- Inflammatory Diseases
- Neurological Diseases
- Oncology
End-User
- Academic Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Cytokines Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cytokines Market?
What are the technology trends and regulatory frameworks in the Cytokines Market?
What is the market share of the leading vendors in the Cytokines Market?
Which modes and strategic moves are suitable for entering the Cytokines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cytokines Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and focus on precision medicine
5.1.1.2. Use of cytokines for the development of protective immunity vaccines
5.1.1.3. Rising importance of cytokines in regenerative medicine
5.1.2. Restraints
5.1.2.1. Issues of dose-dependant toxicity and complex manufacturing of cytokines
5.1.3. Opportunities
5.1.3.1. Research activities supporting advanced cytokine biomarker discovery
5.1.3.2. Advancements in gene editing and effective modification of cytokine expression
5.1.4. Challenges
5.1.4.1. Regulatory hurdles in clinical applications of cytokines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cytokines Market, by Type

6.1. Introduction
6.2. Chemokines
6.3. Colony-Stimulating Factors
6.4. Interferons
6.5. Interleukins
6.6. Tumor Necrosis Factors

7. Cytokines Market, by Source

7.1. Introduction
7.2. Natural Cytokines
7.3. Recombinant Cytokines

8. Cytokines Market, by Route of Administration

8.1. Introduction
8.2. Injectable
8.3. Oral

9. Cytokines Market, by Application

9.1. Introduction
9.2. Autoimmune Diseases
9.3. Inflammatory Diseases
9.4. Neurological Diseases
9.5. Oncology

10. Cytokines Market, by End-User

10.1. Introduction
10.2. Academic Research Institutes
10.3. Hospitals & Clinics
10.4. Pharmaceutical & Biotechnology Companies

11. Americas Cytokines Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cytokines Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Cytokines Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. AbbVie Inc.
15.1.2. Alkem Laboratories Ltd.
15.1.3. Amgen Inc.
15.1.4. AstraZeneca PLC
15.1.5. Bio-Techne Corporation
15.1.6. Bristol-Myers Squibb Company
15.1.7. Cipla Ltd.
15.1.8. Emcure Pharmaceuticals Ltd.
15.1.9. Enzo Life Sciences, Inc.
15.1.10. GlaxoSmithkline PLC
15.1.11. Glenmark Pharmaceuticals Ltd.
15.1.12. Global Calcium Private Limited
15.1.13. Hetero Drugs Ltd.
15.1.14. Intas Pharmaceuticals Ltd.
15.1.15. Ipca Laboratories Ltd.
15.1.16. Johnson & Johnson Services, Inc.
15.1.17. Manus Aktteva Biopharma LLP
15.1.18. Merck KGaA
15.1.19. Novartis AG
15.1.20. Pfizer Inc.
15.1.21. Reliance Life Sciences
15.1.22. Sanofi SA
15.1.23. Sartorius AG
15.1.24. Taj Pharmaceuticals Ltd.
15.1.25. Torrent Pharmaceuticals Ltd.
15.1.26. UCB S.A
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. CYTOKINES MARKET RESEARCH PROCESS
FIGURE 2. CYTOKINES MARKET SIZE, 2023 VS 2030
FIGURE 3. CYTOKINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CYTOKINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CYTOKINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CYTOKINES MARKET DYNAMICS
FIGURE 7. CYTOKINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CYTOKINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CYTOKINES MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. CYTOKINES MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CYTOKINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. CYTOKINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CYTOKINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. CYTOKINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CYTOKINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CYTOKINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CYTOKINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CYTOKINES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CYTOKINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CYTOKINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYTOKINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CYTOKINES MARKET SIZE, BY CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CYTOKINES MARKET SIZE, BY COLONY-STIMULATING FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CYTOKINES MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CYTOKINES MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CYTOKINES MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 12. CYTOKINES MARKET SIZE, BY NATURAL CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CYTOKINES MARKET SIZE, BY RECOMBINANT CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. CYTOKINES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CYTOKINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. CYTOKINES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CYTOKINES MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CYTOKINES MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CYTOKINES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. CYTOKINES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CYTOKINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CYTOKINES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 44. CANADA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CYTOKINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. CHINA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. INDIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 162. ITALY CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 182. POLAND CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 187. QATAR CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CYTOKINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CYTOKINES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CYTOKINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CYTOKINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CYTOKINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. CYTOKINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. CYTOKINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. CYTOKINES MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Alkem Laboratories Ltd.
Amgen Inc.
AstraZeneca PLC
Bio-Techne Corporation
Bristol-Myers Squibb Company
Cipla Ltd.
Emcure Pharmaceuticals Ltd.
Enzo Life Sciences, Inc.
GlaxoSmithkline PLC
Glenmark Pharmaceuticals Ltd.
Global Calcium Private Limited
Hetero Drugs Ltd.
Intas Pharmaceuticals Ltd.
Ipca Laboratories Ltd.
Johnson & Johnson Services, Inc.
Manus Aktteva Biopharma LLP
Merck KGaA
Novartis AG
Pfizer Inc.
Reliance Life Sciences
Sanofi SA
Sartorius AG
Taj Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd.
UCB S.A

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 86.98 Billion
Forecasted Market Value ( USD ) by 2030	$ 149.25 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	26

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3253EUR$3,374USD£2,782GBP €3614EUR$3,749USD£3,091GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4121EUR$4,274USD£3,524GBP €4579EUR$4,749USD£3,916GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4988EUR$5,174USD£4,266GBP €5543EUR$5,749USD£4,740GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5856EUR$6,074USD£5,008GBP €6507EUR$6,749USD£5,565GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7591EUR$7,874USD£6,493GBP €8435EUR$8,749USD£7,214GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Vital Proteins for Biomanufacturing Market by Groups (Cytokines, Enzymes & Chemicals, Expression Systems), Function (Diagnostics, Drug Discovery & Development), Indication - Forecast 2024-2030

Cytokines and the Brain. NeuroImmune Biology Volume 6

Global Cell Culture Reagents Market by Product (Antibiotic, Buffer, Cryoprotective), Application (Bioproduction, Diagnostics, Research), End-User - Forecast 2024-2030

The Cytokines of the Immune System. The Role of Cytokines in Disease Related to Immune Response

Biotechnology and Biopharmaceuticals. Transforming Proteins and Genes into Drugs. Edition No. 2

About the Cytokines Market